PET Imaging of Glial Activation in Psychotic Disease States
试验速览
- 阶段
- 1 期
- 状态
- 终止
- 入组人数
- 35
- 试验地点
- 1
- 主要终点
- Sensitivity and Specificity of ([11C]DPA)-713 PET brain imaging in patients with recent onset schizophrenia and in patients with recent onset of mania
研究概览
简要总结
Many neurological diseases, including AIDS dementia, Alzheimer's disease and schizophrenia, involve an inflammatory component thought to specifically involve glial cell activation. The Investigators has been concerned with the development of tools for noninvasive imaging of inflammatory processes in psychotic disease. Here, the investigators aim to use PET-based neuroimaging with carbon-11 N,N-diethyl-2-(4-methoxyphenyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidine-3-acetamide, ([11C]DPA)-713 to quantify regional distribution of translocator protein (TSPO), a putative marker of inflammation, in the brains of patients with schizophrenia and bipolar disorder, type I. The investigators will focus on patients in the early stages of disease (within first five years of onset of schizophrenia diagnosis and within first five years of first manis, respectively) to minimize the confounds of age-, chronic illness-, and medication- effects on our results.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Parallel
- 主要目的
- Diagnostic
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •healthy volunteers 18-65 years of age
- •Patients diagnosed with recent onset schizophrenia (within 5 years of onset), 18-65 years of age
- •Patients diagnosed with recent onset bipolar disorder (within 5 years of onset of first mania), 18-65 years of age
- •screening laboratory tests will be obtained for subjects within a 10 day period prior to the PET study and the results must be within normal limits for gender and age. These tests will be repeated with a 7-day window following the PET study
- •EKG conducted within 10 day period prior to the PET study. The EKG will be repeated within 7 days following the study.
- •Subject agrees to return to the Hospital for a follow-up EKG and laboratory testing of blood and urine.
- •For females of childbearing potential, negative serum pregnancy test within a 10 day period prior to PET study.
排除标准
- •history of recent nosocomial infection,
- •history of chronic neurological disorder, such as multiple sclerosis or epilepsy, or structural,central nervous system (CNS) abnormality such as stroke or arteriovenous malformation,
- •history of head injury with loss of consciousness > 1 hour,
- •history of active substance abuse as defined by substance abuse including alcohol abuse over the 6 months prior to the study,
- •dependence on benzodiazepine medication
- •contraindications to MRI scanning to include pacemakers, metallic implants/prosthesis or prohibitive claustrophobia, etc.
- •contraindications to PET scanning to include pregnancy, etc. For females of childbearing potential, negative serum pregnancy test less than 10 days prior to PET study
- •ECG demonstrating the patient is not in a sinus rhythm or is having acute ischemia.
- •any medical condition that in the opinion of the study investigators would constitute a safety risk to the subject.
研究组 & 干预措施
Patients with Schizophrenia Disorder
Patients with Schizophrenia Disorder will be imaged with [11C] DPA-713
干预措施: [11C]DPA-713 (Drug)
Patients with Bipolar Disorder
Patients with Bipolar Disorder will be imaged with [11C] DPA-713
干预措施: [11C]DPA-713 (Drug)
Control
Normal volunteers will be imaged with [11C] DPA-713
干预措施: [11C]DPA-713 (Drug)
结局指标
主要结局
Sensitivity and Specificity of ([11C]DPA)-713 PET brain imaging in patients with recent onset schizophrenia and in patients with recent onset of mania
时间窗: within five years of onset of schizophrenia or within five years of first manic episode
To determine regional brain uptake of this radioligand in patients with recent onset schizophrenia and in patients with recent onset of mania
次要结局
- PET Imaging of microglial activation(5 years)